Schistosome genomes: a wealth of information.

The blood flukes Schistosoma japonicum and Schistosoma mansoni are the first major human platyhelminth pathogens to have their genome sequences published. The work of two large international consortia offers draft sequence information and detailed analyses presenting a wealth of information addressing, in particular, metabolic and signalling pathways, host-parasite interactions and potential new drug targets. We comment on these breakthroughs and their potential applications in the study and control of schistosomes.

[1]  Feng Liu,et al.  Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource , 2003, Nature Genetics.

[2]  Alan Fenwick,et al.  Schistosomiasis: challenges for control, treatment and drug resistance , 2006, Current opinion in infectious diseases.

[3]  W. Rice,et al.  Efficacies of Zinc-Finger-Active Drugs againstGiardia lamblia , 1998, Antimicrobial Agents and Chemotherapy.

[4]  Eric Ross,et al.  SmedGD: the Schmidtea mediterranea genome database , 2007, Nucleic Acids Res..

[5]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[6]  Anton Simeonov,et al.  Identification of oxadiazoles as new drug leads for the control of schistosomiasis , 2008, Nature Medicine.

[7]  D. Rollinson,et al.  Bidirectional Introgressive Hybridization between a Cattle and Human Schistosome Species , 2009, PLoS pathogens.

[8]  H. Hirai,et al.  Evolution of a novel subfamily of nuclear receptors with members that each contain two DNA binding domains , 2007, BMC Evolutionary Biology.

[9]  T. Geary,et al.  Foreword: Towards markers for anthelmintic resistance in helminths of importance in animal and human health , 2007, Parasitology.

[10]  M. Doenhoff,et al.  Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance , 2006, Expert review of anti-infective therapy.

[11]  J. Webster,et al.  Evolutionary concepts in predicting and evaluating the impact of mass chemotherapy schistosomiasis control programmes on parasites and their hosts , 2008, Evolutionary applications.

[12]  S. Anderson,et al.  Shotgun DNA sequencing using cloned DNase I-generated fragments , 1981, Nucleic Acids Res..

[13]  D. Rollinson,et al.  A wake up call for urinary schistosomiasis: reconciling research effort with public health importance , 2009, Parasitology.

[14]  John P. Overington,et al.  The genome of the blood fluke Schistosoma mansoni , 2009, Nature.

[15]  H. Hirai,et al.  FISH mapping for helminth genome. , 2004, Methods in molecular biology.

[16]  Haiming Wang,et al.  SchistoDB: a Schistosoma mansoni genome resource , 2008, Nucleic Acids Res..

[17]  Dennis J Minchella,et al.  Analysis of regulatory protease sequences identified through bioinformatic data mining of the Schistosoma mansoni genome , 2009, BMC Genomics.

[18]  C. Caffrey,et al.  Recent initiatives and strategies to developing new drugs for tropical parasitic diseases , 2008, Expert opinion on drug discovery.

[19]  Makedonka Mitreva,et al.  Helminth Genomics: The Implications for Human Health , 2009, PLoS neglected tropical diseases.

[20]  Wei Huang,et al.  The Schistosoma japonicum genome reveals features of host–parasite interplay , 2009, Nature.

[21]  T. Anderson,et al.  Genomic linkage map of the human blood fluke Schistosoma mansoni , 2009, Genome Biology.

[22]  C. King,et al.  Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis , 2005, The Lancet.